ClinicalTrials.gov
public full text
Public Domain
R-VRD Followed by Lenalidomide Maintenance in Patients With Waldenstrom's Macroglobulinemia
A multicenter prospective phase II study of rituximab combined, lenalidomide, dexamethasone followed by lenalidomide maintenance in patients with newly diagnosed Waldenström's macroglobulinemia (Ballondor trial)
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- CC-5013 (Lenalidomide) and Rituximab in Waldenstrom's Macroglobulinemia#1008241
- Lenalidomide Plus Rituximab (R) in Non Follicular NHL#454012
- LBH589 in Relapsed or Relapsed and Refractory Waldenstrom's Macroglobulinemia#837535
- Ibrutinib With Rituximab in Adults With Waldenström's Macroglobulinemia#917799
- Bortezomib, Dexamethasone, and Rituximab in Untreated Waldenstroms Macroglobulinemia#903366
Record · ID 1280472
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive